Share Price Performance
On 22 September 2014, the MorphoSys AG share was included in the broad European market index the STOXX Europe 600. This index includes a set number of 600 individual company shares from 18 European countries. The inclusion in the index depends on the share's liquidity and market capitalization.
In the third quarter of 2014, MorphoSys's share capitalized on its positive start to the 2014 fiscal year and further expanded its performance. At the quarter's end on 30 September 2014, the share closed at its year-to-date high of € 77.69 per share. This represented a price increase of 39.1% and a market capitalization for MorphoSys AG of more than € 2 billion. Thus, MorphoSys's shares outperformed the industry's major benchmark indices. During the first nine months of 2014, the NASDAQ Biotechnology Index climbed 20.7%, the TecDAX rose 7.1%, and the DAX Subsector Biotechnology Performance Index increased 14.9%.